Frequency Therapeutics, Inc. [FREQ]

Source: 

Company Overview

Korro Bio, Inc. is a clinical-stage biopharmaceutical company with a mission to discover, develop and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases.